Security National Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$245K Hold
1,500
0.06% 151
2021
Q2
$245K Hold
1,500
0.05% 156
2021
Q1
$226K Hold
1,500
0.05% 157
2020
Q4
$227K Hold
1,500
0.06% 153
2020
Q3
$203K Hold
1,500
0.06% 153
2020
Q2
$205K Hold
1,500
0.06% 150
2020
Q1
$162K Hold
1,500
0.06% 153
2019
Q4
$181K Hold
1,500
0.05% 166
2019
Q3
$149K Hold
1,500
0.05% 174
2019
Q2
$164K Hold
1,500
0.05% 174
2019
Q1
$168K Hold
1,500
0.05% 166
2018
Q4
$145K Hold
1,500
0.05% 170
2018
Q3
$183K Hold
1,500
0.06% 167
2018
Q2
$165K Hold
1,500
0.05% 170
2018
Q1
$160K Hold
1,500
0.05% 177
2017
Q4
$160K Hold
1,500
0.05% 183
2017
Q3
$167K Hold
1,500
0.06% 186
2017
Q2
$155K Hold
1,500
0.05% 191
2017
Q1
$147K Hold
1,500
0.05% 194
2016
Q4
$133K Hold
1,500
0.05% 199
2016
Q3
$145K Hold
1,500
0.05% 193
2016
Q2
$129K Hold
1,500
0.05% 197
2016
Q1
$130K Hold
1,500
0.05% 202
2015
Q4
$169K Hold
1,500
0.07% 180
2015
Q3
$152K Hold
1,500
0.06% 186
2015
Q2
$184K Hold
1,500
0.07% 186
2015
Q1
$172K Buy
+1,500
New +$165K 0.06% 191

Other funds holding IBB

Security National Trust's IBB Position: Q3 2021 in Review

Security National Trust held its iShares Biotechnology ETF (IBB) position steady in Q3 2021 at 1,500 shares worth $245K. The position accounts for 0.06% of the portfolio, ranked #151.

Security National Trust first reported a position in IBB in Q1 2015 and has held it in 27 quarters since. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Security National Trust held 1,500 shares of iShares Biotechnology ETF worth $245K as of Q3 2021.
  • Security National Trust left its iShares Biotechnology ETF share count unchanged in Q3 2021.
  • iShares Biotechnology ETF made up 0.06% of Security National Trust's portfolio in Q3 2021, its #151 holding.
  • Security National Trust first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 27 quarters since.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.